Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.Friday, August 9, 2024Availability, Epidemiological impactRead More
Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccineFriday, August 9, 2024Availability, Epidemiological impactRead More
Estimating the epidemiologic impact of new TB vaccines in high-burden settingsFriday, August 9, 2024Availability, Epidemiological impactRead More
Estimating the epidemiologic impact of new TB vaccines in the U.S.Friday, August 9, 2024Availability, Epidemiological impactRead More
TB case-finding in the context of future vaccinesFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
WHO preferred product characteristics for new tuberculosis vaccineFriday, August 9, 2024Availability, Policy and frameworksRead More
Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomesFriday, August 9, 2024Availability, Policy and frameworksRead More
